THG — what changed in the latest 10-Q
A section-by-section comparison of THG's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2026-07-29 vs the prior 10-Q · 2026-04-30
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +38 | −8 | ~57 | 74 |
| Market risk (Item 3) | Text added/removed | +3 | −1 | ~9 | 29 |
| Controls & procedures | Text added/removed | +3 | −1 | ~8 | 29 |
| Legal proceedings | Text added/removed | +3 | −1 | ~7 | 25 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +2 | −1 | ~2 | 5 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2026-07-29
Consolidated net income for the six months ended June 30, 2026 was $378.4 million, compared to $285.3 million for the six months ended June 30, 2025, an increase of $93.1 million. This increase was primarily due to higher after-tax operating income of $77.2 million and, to a lesser extent, an improv…
to understand the variability in periodic earnings and to evaluate the underlying performance of our operations. Discussion of catastrophe losses in this Management’s Discussion and Analysis includes development on prior years’ catastrophe reserves and, unless otherwise indicated, such development i…
Specialty underwriting profit for the three months ended June 30, 2026 was $42.2 million, compared to $47.8 million for the three months ended June 30, 2025, a decrease of $5.6 million. Catastrophe losses for the three months ended June 30, 2026 were $10.0 million, compared to $14.6 million for the …
Specialty current accident year underwriting profit, excluding catastrophes, was $41.4 million for the three months ended June 30, 2026, compared to $49.9 million for the three months ended June 30, 2025. This $8.5 million decrease was primarily driven by higher current accident year losses in our M…
Six Months Ended June 30, 2026 Compared to Six Months Ended June 30, 2025
Text removed vs the prior filing · source: 10-Q · 2026-04-30
Specialty underwriting profit for the three months ended March 31, 2026 was $56.1 million, compared to $41.2 million for the three months ended March 31, 2025, an increase of $14.9 million. Catastrophe losses for the three months ended March 31, 2026 were $9.6 million, compared to $14.7 million for …
Specialty current accident year underwriting profit, excluding catastrophes, was $51.5 million for the three months ended March 31, 2026, compared to $40.0 million for the three months ended March 31, 2025. The $11.5 million increase in underwriting results was primarily driven by lower current acci…
For the three months ended March 31, 2025, net favorable loss and LAE development, excluding catastrophes, was $20.0 million. Specialty favorable loss and LAE development of $15.9 million was primarily due to lower than expected losses in our Marine and Industrial Property division and, to a lesser …
Reinsurance recoverables were $2,051.7 million and $2,011.1 million at March 31, 2026 and December 31, 2025, respectively, of which $65.1 million and $62.6 million, respectively, represent billable recoverables. A reinsurance recoverable is billable after an eligible reinsured claim is paid by an in…
The increase in net investment income for the three months ended March 31, 2026 was primarily due to the continued investment of operational cashflows, the impact of reinvesting at higher interest rates, and higher partnership income. Income from partnerships can vary significantly from period to pe…
Market risk (Item 3)
Text added vs the prior filing · source: 10-Q · 2026-07-29
In May 2026, the Board authorized a new share repurchase program totaling $700 million, terminating the previously authorized repurchase program.
On May 21, 2026, Dennis F. Kerrigan, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, adopted a trading plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). His 10b5-1 trading plan provides for the exercise, and subsequent sale, o…
No other officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement during the second quarter ended…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
During the three months ended March 31, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmativ…
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2026-07-29
In May 2026, the Board authorized a new share repurchase program totaling $700 million, terminating the previously authorized repurchase program.
On May 21, 2026, Dennis F. Kerrigan, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, adopted a trading plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). His 10b5-1 trading plan provides for the exercise, and subsequent sale, o…
No other officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement during the second quarter ended…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
During the three months ended March 31, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmativ…
Legal proceedings
Text added vs the prior filing · source: 10-Q · 2026-07-29
In May 2026, the Board authorized a new share repurchase program totaling $700 million, terminating the previously authorized repurchase program.
On May 21, 2026, Dennis F. Kerrigan, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, adopted a trading plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). His 10b5-1 trading plan provides for the exercise, and subsequent sale, o…
No other officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement during the second quarter ended…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
During the three months ended March 31, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmativ…
Other information
Text added vs the prior filing · source: 10-Q · 2026-07-29
On May 21, 2026, Dennis F. Kerrigan, the Company’s Executive Vice President, Chief Legal Officer and Corporate Secretary, adopted a trading plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). His 10b5-1 trading plan provides for the exercise, and subsequent sale, o…
No other officer or director adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or a non-Rule 10b5-1 trading arrangement during the second quarter ended…
Text removed vs the prior filing · source: 10-Q · 2026-04-30
During the three months ended March 31, 2026, none of the Company’s directors or officers (as defined in Rule 16a-1(f) of the Exchange Act) adopted, modified, or terminated a contract, instruction or written plan for the purchase or sale of the Company’s securities intended to satisfy the affirmativ…
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice